Inventor · disambiguated record
Audra Lynn Stinchcomb
Also filed as: STINCHCOMB AUDRA · STINCHCOMB AUDRA L · STINCHCOMB AUDRA LYNN
19 granted patents·26 pending applications·491 citations·filing 2000–2024
96Inventor score
Files withZYNERBA PHARMACEUTICALS INC12ALLTRANZ INC7STINCHCOMB AUDRA L7STINCHCOMB AUDRA LYNN6UNIV KENTUCKY RES FOUND3
Top patents by PatentIndex Score
45 records- 0197US9957246B2Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the sameZYNERBA PHARMACEUTICALS INC·Filed 2016·Granted May 1, 2018·48 cites·12 claims
- 0296US8293786B2Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the sameSTINCHCOMB AUDRA LYNN·Filed 2008·Granted Oct 23, 2012·92 cites·26 claims
- 0395US9533942B2Use of cannabidiol prodrugs in topical and transdermal administration with microneedlesZYNERBA PHARMACEUTICALS INC·Filed 2014·Granted Jan 3, 2017·39 cites·16 claims
- 0493US8980942B2Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the sameSTINCHCOMB AUDRA LYNN·Filed 2012·Granted Mar 17, 2015·15 cites·17 claims
- 0593US8227627B2Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the sameSTINCHCOMB AUDRA LYNN·Filed 2008·Granted Jul 24, 2012·15 cites·19 claims
- 0692US8309568B2Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugsSTINCHCOMB AUDRA LYNN·Filed 2009·Granted Nov 13, 2012·18 cites·18 claims
- 0791US2025034104A1Prodrugs of tetrahydrocannabinol compositions comprising prodrugs of tetrahydrocannabinol and methods of using the sameZYNERBA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0890US8449908B2Transdermal delivery of cannabidiolSTINCHCOMB AUDRA L·Filed 2005·Granted May 28, 2013·36 cites·6 claims
- 0990US8435556B2Transdermal delivery of cannabidiolSTINCHCOMB AUDRA L·Filed 2009·Granted May 7, 2013·38 cites·11 claims
- 1090US6569449B1Transdermal delivery of opioid antagonist prodrugsUNIV KENTUCKY RES FOUND·Filed 2000·Granted May 27, 2003·97 cites·22 claims
- 1189US2024217942A1Prodrugs of tetrahydrocannabinol compositions comprising prodrugs of tetrahydrocannabinol and methods of using the sameZYNERBA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1288US2024083866A1Prodrugs of tetrahydrocannabinol compositions comprising prodrugs of tetrahydrocannabinol and methods of using the sameZYNERBA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1387US8481560B2Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonistsSTINCHCOMB AUDRA LYNN·Filed 2011·Granted Jul 9, 2013·13 cites·30 claims
- 1487US7511054B2Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugsALLTRANZ INC·Filed 2007·Granted Mar 31, 2009·14 cites·10 claims
- 1584US10071090B2Oxymorphone transdermal patchBUZZZ PHARMACEUTICALS LTD·Filed 2015·Granted Sep 11, 2018·8 cites·8 claims
- 1684US7229556B1Delivery system for a compositionUNIV KENTUCKY RES FOUND·Filed 2005·Granted Jun 12, 2007·36 cites·28 claims
- 1782US8653271B2Enhancing transdermal delivery of opioid antagonists and agonists using codrugs linked to bupropion or hydroxybupropionSTINCHCOMB AUDRA L·Filed 2007·Granted Feb 18, 2014·5 cites·13 claims
- 1881US2022194916A1Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the sameZYNERBA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1979US7759358B2Oral bioavailable prodrugsCROOKS PETER A·Filed 2004·Granted Jul 20, 2010·11 cites·10 claims
- 2077US10238648B2Abuse deterrent opioid/opioid-antagonist transdermal patchBUZZZ PHARMACEUTICALS LTD·Filed 2015·Granted Mar 26, 2019·3 cites·21 claims
- 2176US2021047284A1Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the sameZYNERBA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2273US2020024248A1Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the sameZYNERBA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2373US2020247774A1Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the sameZYNERBA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2472US2019233387A1Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the sameZYNERBA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2570US2022117884A1Methods and Compostitions for Enhancing the Viability of Microneedle PoresSTINCHCOMB AUDRA LYNN·Filed 2021·Application pending·0 cites
- 2670US2019031637A1Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the sameZYNERBA PHARMACEUTICALS·Filed 2018·Application pending·0 cites
- 2769US9566341B1Compounds including Cox inhibitor moiety and enhanced delivery of active drugs using sameSTINCHCOMB AUDRA·Filed 2012·Granted Feb 14, 2017·3 cites·10 claims
- 2869US2018208572A1Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the sameZYNERBA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2962US9695143B2Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the sameZYNERBA PHARMACEUTICALS INC·Filed 2015·Granted Jul 4, 2017·0 cites·10 claims
- 3061US2009143762A1Methods and Compositions for Enhancing the Viability Of Microneedle PoresALLTRANZ INC·Filed 2008·Application pending·0 cites
- 3160US2015182453A1Methods and compositions for enhancing the viability of microneedle poresAIITRANZ INC·Filed 2014·Application pending·0 cites
- 3259US2019054014A1Methods and compositions for enhancing the viability of microneedle poresF6 PHARMA INC·Filed 2018·Application pending·0 cites
- 3357US2009247619A1Cannabinoid-Containing Compositions and Methods for Their UseUNIV KENTUCKY·Filed 2009·Application pending·0 cites
- 3455US2008008745A1Transdermal delivery of naltrexone hydrochloride, naltrexol hydrochloride, and bis(hydroxy-methyl)propionyl-3-0 ester naltrexone using microneedlesUNIV KENTUCKY RES FOUND·Filed 2007·Application pending·0 cites
- 3550US2013123292A1Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugsALLTRANZ INC·Filed 2012·Application pending·0 cites
- 3648US2012202891A1Cannabinoid-Containing Compositions and Methods for Their UseSTINCHCOMB AUDRA L·Filed 2009·Application pending·0 cites
- 3747US2009246265A1Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonistsALLTRANZ INC·Filed 2009·Application pending·0 cites
- 3847US2012034293A1Transdermal delivery of cannabinoidsSTINCHCOMB AUDRA L·Filed 2011·Application pending·0 cites
- 3946US10022366B2Extending and maintaining micropore viability of microneedle treated skin with lipid biosynthesis inhibitors for sustained drug deliverySTINCHCOMB AUDRA L·Filed 2014·Granted Jul 17, 2018·0 cites·29 claims
- 4045US2012202892A1Cannabinoid-Containing Compositions and Methods for Their UseSTINCHCOMB AUDRA L·Filed 2012·Application pending·0 cites
- 4145US2011052694A1Use of cannabidiol prodrugs in topical and transdermal administration with microneedlesALLTRANZ INC·Filed 2010·Application pending·0 cites
- 4244US2002111377A1Transdermal delivery of cannabinoidsALBANY COLLEGE OF PHARMACY·Filed 2001·Application pending·0 cites
- 4343US2019350876A1Oral thin films comprising plant extracts and methods of making and using sameF6 PHARMA INC·Filed 2017·Application pending·0 cites
- 4434US2011245288A1Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugsALLTRANZ INC·Filed 2011·Application pending·0 cites
- 4532US2010273895A1Formulations of cannabidiol and prodrugs of cannabidiol and methods of using the sameALLTRANZ INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Audra Lynn Stinchcomb files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →